Board
Naim Abu-Freha
Israel
Naim Abu-Freha
Dr. Naim Abu-Freha Born in Tel-Sheva, Negev in Israel, on 31 July 1980
I received my M.D. from the Tuebingen University, Germany at 2005 before becoming resident at internal medicine and then completed my gastroenterology residency at the Soroka Medical Center at 2014.
I am employed as a senior physician at the Institute for Gastroenterology and Hepatology, Soroka University Medical Center and lecturer at the faculty of Health science, Ben-Gurion University, Beer-Sheva, Israel. In addition, I am working in the different HMOs.
Since 2019, the head of the gastroenterology institute, Assuta Beer-Sheva.
I deal with gastroenterology and hepatology in general, and especially with genetic syndrome of the colorectal cancer. I researched different topics in the gastroenterology/Hepatology and different issues regarding the Bedouin Arab minority in southern Israel.
I am one of the founder’s group of the Arab Medical Associations in the Negev (AMAN) and the first Chairman of the Associations since 2015.
Lior Katz
Israel
Lior Katz
My name is Lior. Married + 5 lovely children. I did my GI fellow at the Sheba Medical Center, and my postdoctoral fellowship at the MD Anderson Cancer Center, Houston, Texas.
I retired from the IDF after almost 20 years of military service. My last position was the chief of gastroenterology service. At Sheba, I established the clinic for patients and families at high risk for GI malignancies.
Since 2018, I am the director of the Department of Gastroenterology and Hepatology at the Hadassah-Hebrew University Medical Center.
Since 2020 I am the secretary of the Israeli Association of Gastroenterology and Liver diseases.
My research interest is GI cancer prevention for average risk and high risk patients.
Lev Lichtenstein
Israel
Lev Lichtenstein
Dr. Lev Lichtenstein is the Head of the IBD Unit at Samson Assuta Medical Center (Ashdod), and the acting Head of the Gastroenterology Unit at Clalit (Dan) Medical Services (integrated to the Division of Gastroenterology at Rabin Medical Center). He received his medical degree from
Goldman Medical School, Ben-Gurion University of the Negev; completed GI Fellowship at Rabin Medical Center, and advanced clinical IBD Fellowship at the University of Chicago. His main clinical and research activity is focused on IBD. Dr. Lichtenstein is a clinical consultant at Immunology Department, Weizmann Institute of Sciences. Dr. Lichtenstein is a member of Israeli IBD Section, ECCO and AGA, and serves as Board Member of Israeli Association of Gastroenterology and Liver Diseases.
Michal Openhaim
Israel
Michal Openhaim
Dr. Michal Openhaim is a Gastroenterologist specialist in Clalit health services
2004 M.D Hebrew University, Hadassah Medical Center, Jerusalem. Israel
2005-2010 Internal medicine specialty, Department of Medicine B, Meir Medical Center, Kfar Saba, Israel.
2010-2012 Senior Physician, internal medicine department B in the Meir Medical Center, Kfar Saba, Israel.
2012-2015 Gastroenterology and liver disease specialty, Department of Gastroenterology, Meir Medical Center, Kfar Saba Israel.
2015 – Gastroenterologist in Clalit health services with special interest in IBD.
2020 – member of the Israeli association of gastroenterology and liver diseases
Rifaat Safadi
Israel
Rifaat Safadi
Prof. Rifaat Safadi M.D.
Full Professor in Medicine, Gastroenterology and Hepatology, Faculty of Medicine, Hadassah University Hospital, Jerusalem & a Visiting Scholar, at the Division of Liver Diseases, Mount Sinai School of Medicine in NY. The treasurer of the Israeli Society of Gastroenterology and Liver Diseases (2020-2023). The Chairman of The Israel Association for the Study of the Liver (2013-2016). A leading member of several international Liver associations committees such as European Association for the Study of Liver (EASL, scientific committee and governing board 2007-2010), American Association for the Study of Liver Diseases (AASLD, International Relations Advisory Committee 2010-2012). He is the Director of Liver Unit, Institute of Gastroenterology and Liver Diseases, Division of Medicine, Hadassah, Ein-Karem. Additionally, Director of Liver Unit & Clinical Research Center (since 1998), Holy Family Hospital, Nazareth, Israel. Prof. Safadi had his residency in Internal Medicine & Gastroenterology at Hadassah University Hospital, Jerusalem. His clinical focus is in Fatty Liver Disease, viral hepatitis, Cirrhosis complications and liver cancer, immune diseases of the liver, liver transplantation and inflammatory bowel diseases. With his laboratory team, the interplay research between lymphocyte subsets and hepatic fibrogenesis uncovered novel pathways and challenges. Recently focused on new immune metabolic NK Checkpoints and therapeutic targets, with patents and drug developments. He received many awardees and research grants and published more than 190 manuscripts in high rated professional journals within the clinical and basic research liver fields. He is a reviewer and a member for editorial boards of several academic journals. Prof Safadi is married to Sana and a father of 3 children.
Haim Shirin
Israel
Haim Shirin
Haim Shirin is the Director of the Gastroenterology and Liver Disease Institute at the Shamir Medical Center, Zerifin, Israel, affiliated with the Sackler Faculty of Medicine, Tel Aviv, Israel. Prof. Haim Shirin is a graduate “cum laude” of the Rappaport Faculty of Medicine at Technion – Israel Institute of Technology. He is a specialist in internal medicine and in gastroenterology and liver diseases. After his gastroenterology residency he did a post-doc fellowship in The Herbert Irving Comprehensive Cancer Center at the Columbia University in New-York, USA, where he focused on Helicobacter pylori and gastric cancer.
Prof. Shirin is extremely dedicated to clinical work and in parallel he is doing clinical research. He published more than 100 original papers in peer review journals, many of them in high quality and high IF journals, and presented his studies in national and international meetings. His main field of interest is Helicobacter pylori.
He is an active member of the Israeli Gastroenterological Association (IGA), and Israel Association for the Study of Liver Diseases. He is also an active member of the American Gastroenterological Association.
Recently (2020), he has been elected as the President of the IGA.
Haim Shirin, M.D.
Director, Gastroenterology & Liver Disease Institute
Shamir Medical Center,
Zerifin, Israel
Tel: +972-8-9779722
Fax: +972-8-9779727
email: haimsh@shamir.gov.il
Faculty
Harvey Alter
USA
Harvey Alter
Dr. Alter has spent most of his career in the Department of Transfusion Medicine and has been designated as a Distinguished NIH Investigator, only 1 of 23 to be so named. Dr. Alter was co-discoverer of the Australia antigen that later proved to be a critical marker of the hepatitis B virus and was principal investigator in studies that identified non-A, non-B hepatitis and later showed its identify to HCV. His prospective studies demonstrated how different donor interventions reduced transfusion hepatitis incidence from 30% in 1970 to near zero in 1997. In recognition of his research accomplishments, Dr. Alter was awarded the Landsteiner Prize of the American Association of Blood Banks, the Insem Medal from Institute Pasteur, the Clinical Lasker Award, the Canada Gairdner International Award, the CDC Fries Prize, and in 2020, the Nobel Prize in Physiology and Medicine. He has been elected to both the National Academy of Sciences and the National Academy of Medicine and is a Master of the American College of Physicians.
Ziv Ben Ari
Israel
Ziv Ben Ari
Prof. Ziv Ben Ari received her MD from the Faculty of Medicine at the Technion, Haifa. She specialized in Internal Medicine and served as a Fellow in Hepatology and Liver Transplantation at the Royal Free Hospital, London (1991 -1996).
Prof. Ben Ari is a Professor of Medicine at the Tel Aviv University Sackler School of Medicine and a national and international valued leader in the field of Hepatology. She served as Chairwoman of the Israeli Association for the Study of Liver Disease (2010-2013) and in 2012 established the first Center for Liver Diseases and the Laboratory for liver molecular biology at Sheba Medical Center. She serves currently as chair of the liver committee in the national council of gastroenterology and liver idseases.
Prof. Ben Ari actively participates and presents at numerous national and international meetings and is an active member of the American and European Association for the Study of the Liver. She is Associate Editor of several highly-ranked international medical journals
and a widely sought after international lecturer who herself has been widely published (she has authored over 177 publications).
Professor Ben Ari is the recipient of national awards in Israel for her work and the recipient of over thirty grants from government, research associations, foundations, Tel Aviv University and pharmaceutical companies for her ongoing liver research.
Guy Boeckxstaens
Belgium
Guy Boeckxstaens
Prof. Boeckxstaens obtained his medical degree in 1987 and his PhD degree in 1991. In 1994, he completed his clinical training in Internal Medicine / Gastroenterology and accepted a staff position in the Department of Gastroenterology & Hepatology at the Academic Medical Center in Amsterdam, The Netherlands. In 2005, he became Professor of Neurogastroenterology at the Academic Medical Center and was appointed co-chair of the department of Gastroenterology and head of the gastrointestinal research. In 2007, he accepted a full professorship in Medicine at the University of Leuven (Belgium) in the department of Gastroenterology. He received several national and international prizes and received the prestigious European Research Council (ERC) Advanced Grant in 2014 and in 2019. He was Secretary and President of the Dutch Society of Neurogastroenterology. Currently, he is Associate Editor of Gut, member of the Editorial Board of Neurogastroenterology and Board Member of the Industrial Research Fund of the University of Leuven, Belgium. He served as chair of the Rome IV committee on Fundamentals of Neurogastroenterology–Physiology Motility & Sensation. He has published over 300 peer-reviewed manuscripts and has an H-index of 56. The scientific expertise of the research group of Prof. Boeckxstaens relates to neurogastroenterology and neuro-immune interactions in the gastrointestinal tract. The mechanisms leading to diseases such as achalasia, gastroesophageal reflux disease, irritable bowel disease, inflammatory bowel disease, chronic constipation, functional dyspepsia and postoperative ileus have been the main topics of interest over the past 20 years.
Eugene Chang
USA
Eugene Chang
Dr. Eugene B. Chang is a physician-scientist, the Martin Boyer Distinguished Professor of Medicine, and the Director of the Microbiome Medicine Program at the University of Chicago. He leads a large, multi-disciplinary group of basic and clinical investigators in studies of host-microbe interactions and disease mechanisms of the gut in states of health and disease (primarily complex immune disorders like inflammatory bowel diseases and metabolic disorders like obesity and metabolic syndrome). These studies have been supported through several NIH grants and involve team science collaborations with colleagues from multi-disciplinary backgrounds.
Roy Dekel
Israel
Roy Dekel
Dr. Dekel is a graduate of the Technion’s Faculty of Medicine, and specialized in internal medicine and gastroenterology at Ichilov Hospital. Afterward (2002-2003), he trained as a research fellow in the field of gastrointestinal disorders in Tucson Arizona. During subsequent years he underwent further training in functional disorders in some of the leading centers in the United States in Boston, Chapel Hill and Chicago. Since 2006 he has served as a senior physician at the Institute for digestive and liver diseases at the Tel Aviv medical center. He is a member of the Israeli neurogastroenterology and motility section of the Israeli medical association. His main clinical and research activity is focused on functional and motility disorders of the GI tract.
Liat Deutsch
Israel
Liat Deutsch
Dr. Liat Deutsch (Mlynarsky) is a graduate of the Faculty of Medicine, from the Hebrew university, Jerusalem, Israel. She specialized in internal medicine at “Meir” Medical Center and was the head of the “young internists” committee at the Israel society of internal medicine. Additionally, she specialized in gastroenterology and Liver diseases at the Tel Aviv Sourasky Medical Center in Tel Aviv (TLVMC), Israel.
Since 2016 she has served as senior physician at the Institute of gastroenterology and liver diseases at the TLVMC, and her main clinical activity and research is focused on clinical nutrition. In 2019, she has completed a clinical attachment to the Intestinal Failure Unit in Salford Royal NHS foundation trust, Manchester, UK. Due to her interest in small bowel pathologies, she is also the head of the video capsule endoscopy service at the TLVMC.
Dr. Deutsch is a member of the Israel Gastroenterology Association (IGA), The Israeli Society for Clinical Nutrition and The European Society for Clinical Nutrition and Metabolism and serves as the head of the clinical nutrition committee in the IGA.
Dr. Liat Deutsch (Mlynarsky)
Department of Gastroenterology AND Liver disease
Tel-Aviv Sourasky Medical Center
6 Weizman St. Tel-Aviv 64239, Israel.
office: 972-3-6974119
fax: 972-3-6973422
email:
liatml@tlvmc.gov.il
Dr.Liat.Deutsch@gmail.com
Linor Deutsch
Israel
Linor Deutsch
Co-founder and CEO of Lobby 99 and Israel’s first public lobbyist. Linor served in the IDF’s elite 8200 Intelligence Unit, holds an LLB in law and political science, and an M.A in gender studies from Tel Aviv University. She served as parliamentary aide and political advisor in the Knesset, and was later appointed VP of regulation and government affairs at the Israeli Farmers Federation. Linor was chosen as one of the “100 Most Influential Israelis” by The Marker (Haaretz) in 2017 through 2020, Was awarded the 2019 Prize “Defender of Qualitative Government”, and appeared in Calcalist’s 2018 list of 36 most promising young leaders under the age of 36. Linor was also featured in 2019 in “Lady Globes” as one of the twenty most prominent female activists.
Ram Dickman
Israel
Ram Dickman
Deputy Head, Division of Gastroenterology, Beilinson Hospital, Rabin Medical Center
Head, Service of Neurogastroenterology, Beilinson Hospital, Rabin Medical Center
Chair of the Israeli Neurogastroenterology Group, affiliated with the IGA
Councilor, European Society of Neurogastroenterology & Motility (ESNM)
Prof. Ram Dickman main field of research is gastrointestinal dysmotility and functional gastrointestinal disorders focusing on GERD, Dyspepsia – Gastroparesis, IBS, Microbiom – Dysbiosis, Functional Abdominal Pain and Pelvic Floor Disorders
Iris Dotan
Israel
Iris Dotan
Iris Dotan is the Director of the Division of Gastroenterology at the Rabin Medical Center, Petah Tikva, Israel, affiliated with the Sackler Faculty of Medicine, Tel Aviv, Israel. Prof. Dotan received her medical degree from the Sackler Faculty of Medicine. Her postdoctoral fellowship was at the Immunobiology Center, Mount Sinai Medical Center, New York, NY, USA, where she focused on intestinal epithelial cell biology. She is a specialist in internal medicine and in gastroenterology and liver diseases.
Her clinical and research interests focus on biomarker-based stratification of patients with inflammatory bowel diseases and a personalized approach to their treatment and care, biologicals and novel therapies for inflammatory bowel disease, and the follow-up of ulcerative colitis patients before and after restorative proctocolectomy (pouch surgery), in a comprehensive, multidisciplinary pouch clinic. Prof. Dotan conducts translational research in mucosal immunology, focusing on the interactions of intestinal epithelial cells and mucosal lymphocytes with their environment. Prof. Dotan first described the anti-glycan antibodies and their relevance to Crohn’s disease a decade ago, and investigates the role of glycans in intestinal immune responses.
Prof. Dotan published more than a 100 papers in peer-reviewed journals. She is the past President of the Israeli Association of Gastroenterology and Liver Diseases, a member of ECCO, the deputy chair IOIBD, and the Immunology and IBD section of the AGA.
Iris Dotan, M.D.
Director, Division of Gastroenterology
Rabin Medical Center,
39 Jabotinsky St. Petah-Tikva 49100, Israel
Tel: +972-3-9377237
Fax: +972-3-9210313
email: irisdo@clalit.org.il
Nathan Gluck
Israel
Nathan Gluck
Director, GI Malignancy Unit, Department of Gastroenterology
Research Center for Digestive Tract & Liver Diseases, Tel Aviv Sourasky Medical Center
Senior lecturer in Internal Medicine, Sackler Medical School, Tel Aviv University
Nathan Gluck received his MD and PhD degrees in biochemistry from the Hebrew University and a postdoctorate at the University of Michigan. He is a board certified gastroenterologist focused on cancer genetics and prevention. His leads an independent research group at Research Center for Digestive Tract & Liver Diseases and has been awarded numerous competitive research grants.
Ian Gralnek
Israel
Ian Gralnek
Ian Gralnek is Clinical Professor of Medicine / Gastroenterology at the Rappaport Faculty of Medicine, Technion-Israel Institute of Technology and Chairman of the Ellen and Pinchas Mamber Institute of Gastroenterology and Hepatology at Emek Medical Center, Afula, Israel.
He is also the recipient of the Dr. Paul and Rose N. Geyser Chair in Clinical Radiology from the Technion Israel Institute of Technology.
Professor Gralnek is currently the Secretary General of the European Society of Gastrointestinal Endoscopy (ESGE) and he will be the ESGE President-Elect starting in March 2021.
Assaf Issachar
Israel
Assaf Issachar
2004: M.D. – Sackler School of Medicine, Tel Aviv University, Tel aviv, Israel
2010 Internal medicine specialty, Department of Medicine D, Rabin Medical Center, Beilinson Campus, Petah Tiqva, Israel.
2014 Gastroenterology and liver disease specialty, Department of Gastroenterology, Rabin Medical Center, Beilinson Campus, Petah- Tiqva, Israel.
2015-2016- post graduate clinical fellowship in transplant hepatology, Toronto general hospital and Toronto univercity, Toronto, Canada
2016-2019- Senior physician Liver institute and Medicine department D, Rabin Medical Center, Beilinson Campus, Petah- Tiqva, Israel.
Since 2019- Head of the living donor liver transplantation service, Liver institute, Rabin Medical Center, Beilinson Campus, Petah- Tiqva, Israel
Ralf Kiesslich
Germany
Ralf Kiesslich
Professor Ralf Kiesslich (50 years) is full professor since 2007 at Gutenberg University Mainz. Germany. He is currently the head of the department of gastroenterology at the Helios HSK Clinic in Wiesbaden, which is the biggest teaching hospital of the university of Mainz. He is also the medical director of the HSK Wiesbaden.
His special research interest is imaging in endoscopy – he firstly described the technique of endomicroscopy.
He is internationally recognized and has published more than 300 scientific manuscripts.
Reut Lutsky
Israel
Reut Lutsky
Dr. Reut Lutski is the head of Gastroenterology institute in Zevulun clinic (Clalit medical services), Kiryat Bialik, and a senior gastroenterologist in Carmel medical center, Haifa.
Her special interest field is clinical nutrition. She is responsible for the parenteral nutrition service in Carmel medical center and the head of the local TPN committee.
Dr. Lutski graduated from the Hebrew University, Jerusalem, and completed her internships in Internal Medicine and in Gastroenterology and Liver disease in Carmel medical center.
Steven Moss
USA
Steven Moss
Dr. Moss grew up in London, England, and graduated from University College London Medical School. He completed a gastroenterology fellowship at the Royal Postgraduate Medical School (Hammersmith Hospital) in London, and a second gastroenterology fellowship in New York, USA, at St. Luke’s-Roosevelt Hospital (Columbia University). After fellowship, Dr. Moss was appointed Assistant Professor of Medicine at Columbia University in New York in 1995. In 2000, he moved to Brown University in Providence, RI as an Associate Professor. In 2009, he was promoted to Professor of Medicine at Brown. He is currently the Program Director of the Gastroenterology Fellowship Training Program at Brown, works as a clinical gastroenterologist/endoscopist and performs research in H. pylori pathogenesis and therapy. He has received awards and research funding from the American Gastroenterology Association (Funderburg Gastrric Cancer award) and the US National Institutes of Health, served as a consultant to the WHO, and has been on the Editorial Boards of Gastroenterology, Gut, American Journal of Gastroenterology and Helicobacter. He is currently a councilor of the American Gastroenterology Association (EGD section). He is a member of the Royal College of Physicians (UK), an American Gastroenterology Association Fellow, and a Fellow of the American College of Gastroenterology.
Anat Nevo-Shore
Israel
Anat Nevo-Shore
Graduated from Josie and Ervine Goldman medical school, Ben-Gurion University in 2009
Finished residency in internal medicine, Soroka Medical Center in 2014 and fellowship in Gastroenterology, Soroka Medical Center, 2019. I am serving as senior gastroenterologist in the Gastroenterology department in Soroka since then.
Special interest in Neurogastroenterology and esophageal diseases
Responsible for the gastroenterology course in Recanati School for Community Health Professions, and teacher for gastroenterology Josie and Ervine Goldman medical school and the Medical school of international Health, Ben-Gurion University
Remo Panaccione
Canada
Remo Panaccione
Dr. Panaccione is currently the Dean of Admissions and Professor of Medicine at the Cumming School of Medicine where he also acts as the Director of the Inflammatory Bowel Disease Clinic and Gastroenterology Research at the University of Calgary.
He is the 2020 Crohn’s Colitis Canada Outstanding Physician of the Year and has been recently recognized as a 2020 Clarivate Research Scholar for being cited in the top 1% of researchers cited in the world.
He is the author of many peer-reviewed articles (~300) including publications in journals such as the New England Journal of Medicine, Lancet, JAMA, Nature, and Annals of Internal Medicine. His special interest lies in the fields of advanced therapies, biological therapy, and delivery of care through the implementation of clinical trials. He is a recognized authority on the use of biologics and has co-authored numerous guidelines on the use of biologics for the Canadian Association of Gastroenterology. He actively participates in clinical trials of new therapeutic agents in Crohn’s disease and ulcerative colitis. He reviews for prestigious journals including NEJM, Lancet, Gastroenterology and Gut.
Ayelet Partoush Abbou
Israel
Ayelet Partoush Abbou
Dr Ayelet Partoush Abbou, married + 4.
A graduate of the Rappaport Faculty of Medicine at Technion – Israel Institute of Technology.
Senior gastroenterologist and hepatologist at Bnai-Zion Medical Centre.
Active as a consultant in the field of gastroenterology and hepatology at Meuhedet Health Fund.
Initiator of a joint research with the Cardiovascular Unit in Bnai-Zion regarding the association between NAFLD and Cardiovascular Diseases.
Medical Students instructor at the Gastroenterology Unit in Bnai-Zion and a lecturer in the Rappaport Faculty of Medicine at Technion.
A member of the Israeli Gastroenterological Association, and Israel Association for the Study of Liver Diseases and the European association for the study of the Liver.
Laurent Peyrin-Biroulet
France
Laurent Peyrin-Biroulet
Full Professor of Medicine
IBD Unit, Inserm U1256
Department of Gastroenterology
Nancy University Hospital, France
Email: peyrinbiroulet@gmail.com
Laurent Peyrin-Biroulet is professor of medicine and head of the inflammatory bowel disease (IBD) unit (Inserm U1256 NGERE) at the Nancy University Hospital in France. Upon receiving his medical degree and PhD, he undertook a postdoctoral fellowship at the IBD Centre in Lille in 2007, before taking a research position at the Mayo Clinic in Rochester, USA (2008–2009).
Professor Peyrin-Biroulet received a rising star award in 2008 from the United European Gastroenterology Federation (UEGF). He is President of the GETAID and Past-President of the SciCom of the French association of IBD patients (AFA). He is past-Chair of the IBD Committee of the French Society of Digestive Endoscopy (SFED) and Past-Chair of the Clinical Trials Task Force at IOIBD. He was member of the UEGF Scientific Committee (2011-14). He is the current President elect of the European Crohn’s & Colitis Organization (ECCO) and current scientific secretary of IOIBD. He was the coordinator for the development of the first Disability Index for IBD and of the treat to target (STRIDE) recommendations. He proposed the first definitions of early Crohn’s disease and of disease severity for IBD. He is co-founder of the Spectrum consortium and President of the ICARE project. Author of more than 700 peer-reviewed articles and more than 200 non peer-reviewed articles, Professor Peyrin-Biroulet was an associate editor of Digestive Liver Diseases (2013-17), and is a member of the editorial board of Alimentary Pharmacology & Therapeutics, Journal of Crohn’s and colitis, Expert Review of Clinical Immunology, and Gut. He is Associate Editor of Clinical Gastroenterology Hepatology since 2017. He also serves as a reviewer for several international journals and he is a staff contributor of the Selected Summary section of Gastroenterology. He joined the editorial team of the Cochrane Inflammatory Bowel Diseases and Functional Bowel Disorders (IBD/FBD) Review Group in 2014. He served as Councillor to the Immunology, Microbiology and IBD section of the AGA Institute Council (2014-2016).
Ehud Rinott
Israel
Ehud Rinott
Ehud Rinott is a MD-PhD student in the Iris Shai research group from Ben Gurion University of the Negev.
Ehud Studies the association between the gut microbiome in health and disease in the overweight population, exploring various weight-loss strategies by targeting the gut microbiome.
David Rubin
USA
David Rubin
Dr. David T. Rubin is the Joseph B. Kirsner Professor of Medicine, Chief of the Section of Gastroenterology, Hepatology & Nutrition and the Co-Director of the Digestive Diseases Center at The University of Chicago Medicine. Dr. Rubin earned a medical degree with honors at The University of Chicago Pritzker School of Medicine. He completed his residency in internal medicine and fellowships in gastroenterology and clinical medical ethics at the University of Chicago, where he served as Chief Resident and Chief Fellow. Prior to his current appointments, Dr. Rubin served for 11 years as Director of the Gastroenterology, Hepatology and Nutrition fellowship program. He also currently serves as an associate faculty member at the MacLean Center for Clinical Medical Ethics and an associate investigator at the University of Chicago Comprehensive Cancer Center.
Dr. Rubin is a Fellow of the American Gastroenterological Association (AGA), the American College of Gastroenterology (ACG), the American Society for Gastrointestinal Endoscopy (ASGE) and the American College of Physicians (ACP) and an active national member of the Crohn’s & Colitis Foundation, and is on the Board of Trustees for the ACG. Among numerous awards and honors, Dr. Rubin was the recipient of the 2020 Sherman Prize for excellence in IBD, and has been chosen by his peers as a member of Best Doctors (recognized for superior clinical ability) and America’s Top Physicians (gastroenterology). Additionally, he twice received the ACG’s Governor’s Award of Excellence in Clinical Research (2003 and 2013), the UChicago Cancer Research Foundation Young Investigator’s Award (2004), and the UC Postgraduate Teaching Award in recognition of significant contributions for fellowship education (2006). In 2012, he received the CCF Rosenthal Award, a national leadership award bestowed upon a volunteer who has contributed in an indisputable way to the quality of life of patients and families. He is currently the Chair-elect of the National Scientific Advisory Committee of the Crohn’s and Colitis Foundation. He is an Associate Editor of the journal Gastroenterology and Editor of the ACG On-Line Educational Universe.
Dr. Rubin is the editor of a best-selling book on inflammatory bowel disease (IBD), now in its 3rd edition, an associate editor of the now available 11th edition of Sleisenger and Fordtran’s Gastrointestinal and Liver Disease, and an author or coauthor of many peer-reviewed articles on treatment and management of IBD, cancer in IBD and novel paradigms, as well as the first author of the 2019 ACG Guidelines for ulcerative colitis. His current research is in the area of progressive complications from uncontrolled inflammation and a variety of collaborative studies related to the microbiome and intestinal disease. He is also a featured media contact for issues related to IBD, appearing on satellite radio, television, print media and maintains a popular and verified twitter feed @IBDMD (>15,000 followers). His principal research interests include novel IBD therapies and outcomes and clinical medical ethics.
Reem Sharaiha
USA
Reem Sharaiha
Dr. Reem Sharaiha is an Associate Professor of Medicine at the Weill Medical College of Cornell University. She is the director of Interventional and Therapeutic endoscopy as well as the director of bariatric and metabolic endoscopy. She is an expert advanced endoscopist in pancreaticobiliary disease and in endoscopic (non surgical) treatment for weight loss and the improvement of weight-related health conditions. She is board certified in gastroenterology, internal medicine, and obesity (in both the United States and UK) and is also an advanced fellowship trained interventional gastroenterologist. She received her medical degree from the University of London (St George’s Hospital). She completed her Internal Medicine residency at New York Presbyterian Hospital-Weill Cornell Campus and her fellowship at New York Presbyterian Hospital-Columbia Campus, where she received a masters in patient oriented research (biostatistics). She completed her Fellowship training in Gastroenterology at Columbia University Medical Center, and her Advanced Endoscopy Fellowship at Johns Hopkins University Hospital. Her research is primarily focused on interventional endoscopy. A major focus of her research is on endoscopic treatment options for obesity, as well as ablation therapies for malignancy and treatment of pancreatic fluid collections. She is also grant funded. Her objectives are to develop and understand the new endoscopic techniques for reducing the obesity epidemic, and understand the safety and efficacy of such techniques and their impact on comorbidities.
Pierre Singer
Israel
Pierre Singer
Dr. Singer has over 35 years of clinical and academic experience. He was born in France and has made his medical school at the Louis Pasteur faculty of Medicine of Strasbourg (France). Boarded in gastroenterology and nutrition as well as in intensive care, he is currently director of the General Intensive Care Department, Rabin Medical Center, Beilinson Campus, Petach Tikva, Israel (1995-present), Full Professor of Anesthesia and Intensive Care at the Sackler school of medicine, Tel Aviv University, head of the Institute of Nutrition Research (2006-present) at Rabin Medical Center, Chair of the Eduarda and Dr Moshe Ishay Institute for the Study of the Effects of Natural Food on the Quality of Life and Human Health at the Tel Aviv University, and director of the Metabolism Laboratory at the Felsenstein Medical Research Center. Dr. Singer was President (2003), Treasurer (2004-2008) and Chairman of the European Society for Clinical Nutrition and Metabolism (ESPEN) (2010-2014) and the co-chairman of the ESPEN Guidelines editorial board (2014-2018). He is an honorary member of ESPEN (2018), from the Cech, Hungarian society and the Philippines society of Parenteral and enteral Nutrition.
His research is focused on metabolism and nutrition mainly in the critically ill, but also in artificial intelligence. He is the editor in chief of Clinical Nutrition Experimental, an associate editor, section editor or co-editor of Intensive Care Medicine, Clinical Nutrition, Nutrition, Nutrition in Clinical Practice or JPEN. He is co-principal author of the teaching modules on Nutrition in the ICU from ESPEN (LLL) as well as of the ESPEN: Nutrition in the ICU 2019 guidelines. He is cooperating with many international centers in terms of research such as Geneva, Lausanne, Brussels, Parma, Hamilton (CN), Warshaw, Vienna, Madrid, Dallas, Houston in terms of research.
Dr. Singer has presented over 400 lectures internationally, and had more than 250 invited papers at scientific meetings. He has published more than 185 original articles, 65 review articles, 42 book chapters, and more than 400 abstracts. He has been cited more than 18,000 times (more than 2900 times in 2019) and his index-h is 55.
Johanna Torres
Portugal
Johanna Torres
Joana Torres received her medical degree from the University of Coimbra, Portugal, and completed her fellowship in Gastroenterology at the Hospital Center of Coimbra, Portugal. After post-doctoral training in Icahn School of Medicine at Mount Sinai, New York she completed her PhD at Medicine Faculty, University of Lisbon, and was appointed Assistant Professor. She is currently working in Hospital Beatriz Ângelo, Loures, Portugal as a Gastroenterology Assistant. She is an active member of the European Crohn and the current chair of the Ecco´s Guideline committee (GuiCom).
Joana Torres has given several invited lectures at international meetings and has authored more than 70 scientific papers in peer-reviewed journals. Her research focus in populations at risk for developing inflammatory bowel disease with the goal of better understanding the events taking place before disease is diagnosed, with the aim of finding better treatments and developing preventive strategies.
Dan Turner
Israel
Dan Turner
Shaare Zedek Medical Center, The Hebrew University of Jerusalem, Israel
Dan Turner is Professor of Paediatrics at the Hebrew University of Jerusalem. Professor Turner has been Head of the Juliet Keidan Institute of Paediatric Gastroenterology and Nutrition at the Shaare Zedek Medical Center, Jerusalem, since 2008, and is Director of the Paediatric Inflammatory Bowel Disease (IBD) Center and its research unit, leading more than 30 concurrent studies in PIBD. He has co-chaired the European Crohn’s Colitis Organization (ECCO) and European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) guidelines for the treatment of children with IBD. Professor Turner is a Vice-President of the international PIBD network, and an elected member of the International Organization of Inflammatory Bowel Diseases (IOIBD). He is the past chair of the Paediatric committee of ECCO and the Paediatric IBD Porto Working Group of ESPGHAN. He has authored over 200 peer-reviewed manuscripts in the field of IBD.
Elez Vainer
Israel
Elez Vainer
Dr. Elez Vainer is a senior physician in the Gastroenterology department at Hadassah Medical Center. She has received her medical degree from the Hebrew University, Hadassah Medical Center, Jerusalem. She completed her residency in internal medicine at Meir Medical Center, and continued to a gastroenterology fellowship in Hadassah Medical Center.
Today she is in charge of the gastro-genetic clinic in Hadassah Medical Center
She’s involved in clinical and basic research in the field of proteomics and IBD and hereditary cancer.
Thank you to our Oral Abstract Presenters, scheduled in the program
Fadi Abu Baker, Israel
Irit Avni-Biron, Israel
Anton Bermont, Israel
Daniel Cohen, Israel
Ana Grinman, Israel
Tom Konikoff, Israel
Yael Milgrom, Israel
Joel Schifter, Israel
Igor Uchitel, Israel
Batia Weiss, Israel
Dov Wengrower, Israel
Dana Zelnik Yovel, Israel